Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Pei XuJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.
Hao-Qiang JiangJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.
Hui XuJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.
Sai WangJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.ORCID https://orcid.org/0009-0003-4714-9355
Hui-Xian JiangJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.
Song-Lei ZhuJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.
Long YinJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.
Dong GuoJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.ORCID https://orcid.org/0000-0001-6142-4825
Xu ZhuJiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University 209 Tongshan Road Xuzhou 221004 China longyin@xzhmuedu.cn guo@xzhmu.edu.cn xuzhu@xzhmu.edu.cn.ORCID https://orcid.org/0000-0002-8856-2045
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Herein, a catalytic photoredox-neutral strategy for alkyne deuterocarboxylation with tetrabutylammonium oxalate as the carbonyl source and D
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Photocatalytic deuterocarboxylation of alkynes with oxalate. · full record | OpenQuestion